The role of T-fimbrin in the response to DNA damage: Silencing of T-fimbrin by small interfering RNA sensitizes human liver cancer cells to DNA-damaging agents

International Journal of Oncology

Volumn 27, Issue 4, 2005, Pages 933-940

  Ikeda, Hiroshi ^a   Sasaki, Yasushi ^a   Kobayashi, Toshihisa ^a   Suzuki, Hiromu ^a   Mita, Hiroaki ^a   Toyota, Minoru ^a   Itoh, Fumio ^b   Shinomura, Yasuhisa ^a   Tokino, Takashi ^a   Imai, Kohzoh ^c  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Chemosensitivity; Liver cancer; SiRNA; T fimbrin

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ACTIN; ACTIN BINDING PROTEIN; ANTINEOPLASTIC AGENT; AZACITIDINE; CARCINOGEN; DRUG DERIVATIVE; ETOPOSIDE; FIMBRIN; ISOPROTEIN; MEMBRANE PROTEIN; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL SEPARATION; CHEMISTRY; CYTOSKELETON; DNA DAMAGE; DNA METHYLATION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; IMMUNOBLOTTING; LIVER TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TIME; TUMOR CELL LINE; ULTRAVIOLET RADIATION;

ACTINS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; AZACITIDINE; CARCINOGENS; CELL CYCLE; CELL LINE, TUMOR; CELL SEPARATION; CYTOSKELETON; DNA DAMAGE; DNA METHYLATION; ETOPOSIDE; FLOW CYTOMETRY; G2 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; IMMUNOBLOTTING; LIVER NEOPLASMS; MEMBRANE GLYCOPROTEINS; MICROFILAMENT PROTEINS; MICROSCOPY, FLUORESCENCE; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TIME FACTORS; TRANSFECTION; ULTRAVIOLET RAYS;

EID: 33644824839     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.27.4.933     Document Type: Article

References (45)

1. Bosch FX, Ribes J and Borras J: Epidemiology of primary liver cancer. Semin Liver Dis 19: 271-285, 1999.
2. Di Maio M, De Maio E, Perrone F, Pignata S and Daniele B: Hepatocellular carcinoma: systemic treatments. J Clin Gastroenterol 35: 109-114, 2002.
3. Jordan MA and Wilson L: Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr Opin Cell Biol 10: 123-130, 1998.
4. Martin SJ and Green DR: Apoptosis as a goal of cancer therapy. Curr Opin Oncol 6: 616-621, 1994.
5. Zunino F, Perego P, Pilotti S, Pratesi G, Supino R and Arcamone F: Role of apoptotic response in cellular resistance to cytotoxic agents. Pharmacol Ther76: 177-185, 1997.
6. Kaufmann SH and Earnshaw WC: Induction of apoptosis by cancer chemotherapy. Exp Cell Res 256: 42-49, 2000.
7. Mow BM, Blajeski AL, Chandra J and Kaufmann SH: Apoptosis and the response to anticancer therapy. Curr Opin Oncol 13: 453-462,2001.
8. Lebedeva I, Rando R, Ojwang J, Cossum P and Stein CA: Bcl-xL in prostate cancer cells: effects of overexpression and downregulation on chemosensitivity. Cancer Res 60: 6052-6060, 2000.
9. Rogers PM, Beale PJ, Al-Moundhri M, et ah. Overexpression of BclXL in a human ovarian carcinoma cell line: paradoxic effects on chemosensitivity in vitro versus in vivo. Int J Cancer 97: 858-863, 2002.
10. Meyn MS: Ataxia-telangiectasia and cellular responses to DNA damage. Cancer Res 55: 5991-6001, 1995.
11. Bunz F, Hwang PM, Torrance C, et ah. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J Clin Invest 104: 263-269, 1999.
12. Stewart ZA, Westfall MD and Pietenpol JA: Cell-cycle dysregulation and anticancer therapy. Trends Pharmacol Sci 24:139-145,2003.
13. Iliakis G, Wang Y, Guan J and Wang H: DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene 22:5834-5847,2003.
14. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311, 1991.
15. El-Deiry WS: Regulation of p53 downstream genes. Semin Cancer Biol 8: 345-357, 1998.
16. Tokino T and Nakamura Y: The role of p53-target genes in human cancer. Crit Rev Oncol Hematol 33: 1-6, 2000.
17. Toyota M, Sasaki Y, Satoh A, et ah Epigenetic inactivation of CHFR in human tumors. Proc Natl Acad Sci USA 100: 7818-7823,2003.
18. Satoh A, Toyota M, Itoh F, el ah Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer. Cancer Res 63: 8606-8613, 2003.
19. Rao J and Li N: Microfilament actin remodeling as a potential target for cancer drug development. Curr Cancer Drug Targets 4: 345-354, 2004.
20. Khosravi-Far R and Der CJ: The Ras signal transduction pathway. Cancer Metastasis Rev 13: 67-89, 1994.
21. Symons M: The Rac and Rho pathways as a source of drug targets for Ras-mediated malignancies. Curr Opin Biotechnol 6: 668-674, 1995.
22. Wells A: Tumor invasion: role of growth factor-induced cell motility. Adv Cancer Res 78: 31-101, 2000.
23. Buda A and Pignatelli M: Cytoskeletal network in colon cancer: from genes to clinical application. Int J Biochem Cell Biol 36: 759-765, 2004.
24. Sakai N, Ohtsu M, Fujita H, Koike T and Kuzumaki N: Enhancement of G2 checkpoint function by gelsolin transfection in human cancer cells. Exp Cell Res 251: 224-233, 1999.
25. Liu A, Cerniglia GJ, Bernhard EJ and Prendergast GC: RhoB is required to mediate apoptosis in neoplastically transformed cells after DNA damage. Proc Natl Acad Sci USA 98: 6192-6197, 2001.
26. Yuan Y and Shen Z: Interaction with BRCA2 suggests a role for filamin-1 (hsFLNa) in DNA damage response. J Biol Chem 276: 48318-48324,2001.
27. Lin CS, Aebersold RH, Kent SB, Varma M and Leavitt J: Molecular cloning and characterization of plastin, a human leukocyte protein expressed in transformed human fibroblasts. Mol Cell Biol 8: 4659-4668, 1988.
28. Correia I and Matsudaira P: Fimbrin. In: Guidbook to the Cytoskeletal and Motor Proteins. Kreis T and Vale R (eds). Oxford University Press, Oxford, pp97-99, 1999.
29. Sasaki Y, Itoh F, Kobayashi T, et ah. Increased expression of T-fimbrin gene after DNA damage in CHO cells and inactivation of T-fimbrin by CpG methylation in human colorectal cancer cells. Int J Cancer 97: 211-216, 2002.
30. Sasaki Y, Morimoto I, Ishida S, Yamashita T, Imai K and Tokino T: Adenovirus-mediated transfer of the p53 family genes, p73 and p51/p63 induces cell cycle arrest and apoptosis in colorectal cancer cell lines: potential application to gene therapy of colorectal cancer. Gene Ther 8: 1401-1408, 2001.
31. Sasaki Y, Mita H, Toyota M, et at. Identification of the interleukin 4 receptor alpha gene as a direct target for p73. Cancer Res 63: 8145-8152, 2003.
32. Lin CS, Lau A, Huynh T and Lue TF: Differential regulation of human T-plastin gene in leukocytes and non-leukocytes: identification of the promoter, enhancer, and CpG island. DNA Cell Biol 18: 27-37, 1999.
33. Brown JM and Wouters BG: Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res 59: 1391-1399, 1999.
34. Hisano T, Ono M, Nakayama M, Naito S, Kuwano M and Wada M: Increased expression of T-plastin gene in cisplatinresistant human cancer cells: identification by mRNA differential display. FEBS Lett 397: 101-107, 1996.
35. Higuchi Y, Kita K, Nakanishi H, et at Search for genes involved in UV-resistance in human cells by mRNA differential display: increased transcriptional expression of nucleophosmin and Tplastin genes in association with the resistance. Biochem Biophys Res Commun 248: 597-602, 1998.
36. Rao KM and Cohen HJ: Actin cytoskeletal network in aging and cancer. Mutat Res 256: 139-148, 1991.
37. De Arruda MV, Watson S, Lin CS, Leavitt J and Matsudaira P: Fimbrin is a homologue of the cytoplasmic phosphoprotein plastin and has domains homologous with calmodulin and actin gelation proteins. J Cell Biol 111: 1069-1079, 1990.
38. Su MW, Dorocicz I, Dragowska WH, et at. Aberrant expression of T-plastin in Sezary cells. Cancer Res 63: 7122-7127, 2003.
39. Hartwell LH and Weinert TA: Checkpoints: controls that ensure the order of cell cycle events. Science 246: 629-634, 1989.
40. Bernhard EJ, Muschel RJ, Bakanauskas VJ and McKenna WG: Reducing the radiation-induced G2 delay causes HeLa cells to undergo apoptosis instead of mitotic death. Int J Radiat Biol 69: 575-584, 1996.
41. Goldwasser F, Shimizu T, Jackman J, et at. Correlations between S and G2 arrest and the cytotoxicity of camptothecin in human colon carcinoma cells. Cancer Res 56: 4430-4437, 1996.
42. Larsen AK and Skladanowski A: Cellular resistance to topoisomerase- targeted drugs: from drug uptake to cell death. Biochim Biophys Acta 1400: 257-274, 1998.
43. McMillan JN, Sia RA and Lew DJ: A morphogenesis checkpoint monitors the actin cytoskeleton in yeast. J Cell Biol 142: 1487-1499, 1998.
44. Rupes I, Webb BA, Mak A and Young PG: G2/M arrest caused by actin disruption is a manifestation of the cell size checkpoint in fission yeast. Mol Biol Cell 12: 3892-3903, 2001.
45. Lew DJ: The morphogenesis checkpoint: how yeast cells watch their figures. Curr Opin Cell Biol 15: 648-653, 2003.